ATAC Trademark

Trademark Overview


On Tuesday, May 21, 2019, a trademark application was filed for ATAC with the United States Patent and Trademark Office. The USPTO has given the ATAC trademark a serial number of 88439354. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by Heidelberg Pharma Research GmbH. The ATAC trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations, namely, anti-cancer and immunosuppression preparations; pharmaceuticals, namely, anti-cancer and immunosuppression preparations; chemico-pharmaceutical preparations, namely, chemical preparations for medical purposes for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances, namely, pharmaceutical products for the treatment of cancer and immunosuppression; pharmaceutical preparations, namely, anti-cancer preparations for veterinary use; chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer and immunosupression; pharmaceutical preparations for human use, namely, pharmaceutical preparations for human use in the treatment of cancer and immnunosupression; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substan...

Pharmaceutical advice; pharmaceutical consultation services; consultancy and information services relating to pharmaceutical products; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression

Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; provision of medical research services; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; pharmaceutical research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific laboratory services relating to the production of monoclonal antibodies; all the aforesaid ...
atac

General Information


Serial Number88439354
Word MarkATAC
Filing DateTuesday, May 21, 2019
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6886783
Registration DateTuesday, November 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, anti-cancer and immunosuppression preparations; pharmaceuticals, namely, anti-cancer and immunosuppression preparations; chemico-pharmaceutical preparations, namely, chemical preparations for medical purposes for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances, namely, pharmaceutical products for the treatment of cancer and immunosuppression; pharmaceutical preparations, namely, anti-cancer preparations for veterinary use; chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer and immunosupression; pharmaceutical preparations for human use, namely, pharmaceutical preparations for human use in the treatment of cancer and immnunosupression; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; diagnostic preparations for veterinary purposes; clinical diagnostic reagents for medical use; diagnostic chemical reagents for medical use; anti-cancer drugs, namely, anti-cancer preparations; pharmaceutical compounds for treating cancer and immunosuppression; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals, namely, anti-cancer preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; antibodies being pharmaceutical preparations for the treatment of cancer and immunosuppression; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression with agents including amatoxin
Goods and ServicesPharmaceutical advice; pharmaceutical consultation services; consultancy and information services relating to pharmaceutical products; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression
Goods and ServicesPharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; provision of medical research services; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; pharmaceutical research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific laboratory services relating to the production of monoclonal antibodies; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 5, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 5, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHeidelberg Pharma Research GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLadenburg 68526
DE

Party NameHeidelberg Pharma Research GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLadenburg 68526
DE

Party NameHeidelberg Pharma Research GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLadenburg 68526
DE

Trademark Events


Event DateEvent Description
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 5, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, January 13, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 13, 2022FINAL REFUSAL E-MAILED
Thursday, January 13, 2022FINAL REFUSAL WRITTEN
Monday, November 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 15, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 5, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 5, 2021INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 5, 2021SUSPENSION INQUIRY WRITTEN
Wednesday, August 25, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, January 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 7, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 7, 2020LETTER OF SUSPENSION E-MAILED
Monday, December 7, 2020SUSPENSION LETTER WRITTEN
Friday, December 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 25, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 23, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, November 23, 2020INQUIRY TO SUSPENSION E-MAILED
Monday, November 23, 2020SUSPENSION INQUIRY WRITTEN
Monday, November 2, 2020SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, November 2, 2020ASSIGNED TO LIE
Wednesday, February 26, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 26, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, February 26, 2020SUSPENSION LETTER WRITTEN
Tuesday, February 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 9, 2019NON-FINAL ACTION E-MAILED
Friday, August 9, 2019NON-FINAL ACTION WRITTEN
Thursday, August 8, 2019ASSIGNED TO EXAMINER
Wednesday, June 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 24, 2019NEW APPLICATION ENTERED IN TRAM